On March 5, FDA Commissioner Dr. Scott Gottlieb abruptly announced his resignation, effective in a month. ..
We’ve been waiting quite a while for the FDA to modernize its positions on the truthful off-label communications ..
We all know the phrase “the elephant in the room.” There are some things that do not get mentioned ..
As we roll out of bed on the day after Thanksgiving, we are often confronted with contradictory thoughts. ..
By Ron Litman The FDA’s Analgesic and Anesthetic Drug Advisory Committee (AADPAC), of which I am a member, ..
Although they have nothing to do with the Affordable Care Act, health-care-related so-called “death ..
We’ve complained before about the federal government’s monetization of First Amendment violations ..
Researchers at Temple University here in Philly recently published a scientific article, “Learning ..